SCHEMBL5318544

SCHEMBL5318544

Cc1cc(Cl)ccc1Cn1nc(CCCO)c2ccc(C(F)(F)F)cc21

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.38
CCR2 P41597 1/20 0.38
SLC22A12 Q96S37 4/20 0.37
CYP2C9 P11712 1/20 0.36
PTGDR2 Q9Y5Y4 3/20 0.35
KMO O15229 1/20 0.34
KCNA3 P22001 1/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
ENPP2 Q13822 1/20 0.34
GCGR P47871 1/20 0.33
MC4R P32245 1/20 0.33
FFAR4 Q5NUL3 1/20 0.33
PTGER1 P34995 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5317649 0.97 AKR1B1 (0.38) AKR1B1CCR2SLC22A12CYP2C9PTGDR2
SCHEMBL5317869 0.96 AKR1B1 (0.37) AKR1B1CCR2SLC22A12CYP2C9PTGDR2
SCHEMBL5270492 0.94 AKR1B1 (0.39) AKR1B1CCR2SLC22A12CYP2C9PTGDR2
SCHEMBL5316051 0.90 NPSR1 (0.42) AKR1B1CCR2SLC22A12CYP2C9NR1H2
SCHEMBL5318259 0.89 KMO (0.46) AKR1B1CCR2SLC22A12PTGDR2KMO
SCHEMBL5320313 0.89 NR1H2 (0.42) AKR1B1CCR2SLC22A12CYP2C9NR1H2
SCHEMBL5316058 0.88 KMO (0.44) AKR1B1CCR2SLC22A12PTGDR2KMO
SCHEMBL5322190 0.87 NPSR1 (0.41) AKR1B1CCR2SLC22A12CYP2C9NR1H2
SCHEMBL5317364 0.86 NPSR1 (0.41) AKR1B1CCR2SLC22A12CYP2C9NR1H2
SCHEMBL5318908 0.86 NR1H2 (0.42) AKR1B1CCR2SLC22A12CYP2C9NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed